Member Info for daveycaferacer

Director Buys shows confidence - a good move

I concur and have also gone Long

courtesy of Lauders on advfn

Https://www.forbes.com/sites/johnlamattina/2018/09/26/chinese-drug-maker-clarifies-development-strategy-for-bringing-cancer-drug-to-the-u-s-market/#448e20b54109

https://www.fiercepharma.com/pharma-asia/china-updates-national-insurance-list-adds-blockbuster-meds-from-foreign-pharma

It appears Seroquel is now on the National Reimbursement Drug List in China, I missed that development. I assume that is a very positive development for the Commercial Platform going forward....

https://www.fiercepharma.com/pharma-asia/big-pharma-s-cancer-drugs-take-50-plus-discount-for-china-s-insurance-scheme

I wonder if they know the criminals of Quindell?

agreed investors, hope it all comes goo makes a recovery

yes

I agree mizman, but some may see the continual slide in the SP as a Red Flag and would rather buy at a higher price when there is an investment case that holds water

tender process will take a very long time

Great buying opp <2p

This could be interesting

"The U.K and China are planning to link their stock exchanges. The London-Shanghai Stock Connect, as it will be known, will allow companies listed on one venue to issue shares on the other." - this will be similar to London Ordinary Shares + U.S ADRs

https://www.bloomberg.com/news/articles/2018-10-10/all-about-the-u-k-china-plan-to-link-stock-markets-quicktake?srnd=premium-europe

Understood Wimbo , thankyou

when there is a Bluefin or some other "off board" chat group like there was with QPP you know it's a Red Flag.

There is something going wrong here too when the Co. says they are investing in "shovel ready" projects that will deliver revenue in the near term - the Co will not have a £ of earnings for years or decades

yes drax, but possibly a reasonable gamble in the 2p arena though, you never know, something positive could actually happen one day

https://in.reuters.com/article/us-china-health-cancer/china-approves-17-anti-cancer-drugs-for-medical-insurance-coverage-idINKCN1MK028?feedType=RSS&feedName=health&utm_source=Twitter&utm_medium=Social&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29

"This acquisition provides Kibo with the realistic possibility of near-term revenue generating asset"

How can revenue be "near term" when the sites are only "shovel ready"?

Those two contradict each other.

I have tremendous confidence, unfortunately the million pound buy was not mine, although I do continue to buy sizeable amounts ;o-)

Agreed Wimbledon, it's not a good idea, but someone needs to do something otherwise what little patience Investors have left disappear .....

The article is optimistic on China Biotech, I am very optimistic on Chi-Med, the market is less so unfortunately......I continue to buy